As outlined in our last Investor Con-call (Jan 2025), Management focus for Q4 remained on reviving Underlying Volume Growth (UVG) growth trajectory in Standalone, hold EBITDA margins in Standalone despite significant cost pressure, and maintain the trajectory in International business performance. We remain largely on track to achieve across all the stated objectives.
Our Standalone UVG is expected to be mid-single digits and revenue growth to be high single digits. This has been driven by a mid-teens UVG in Home Care and mid-single digit decline in Personal Care. Personal Care continues to go through a price-volume rebalancing on account of rising input costs. EBITDA margins are likely to be in a similar range as Q3 FY25 despite high inflation in Palm and related derivates.
Our international businesses continue to do well on their relevant strategic objectives.
Indonesia business is expected to deliver mid-single digit UVG and low-single digit revenue growth.
In line with our guidance, the GAUM (Godrej Africa, USA, and Middle East) organic business is likely to deliver strong double digit organic UVG and revenue growth. We continue to do well on our profitability.
At a Consolidated (organic) level, we expect high-single digit INR sales growth with midsingle digit UVG.
This update provides an overall summary of the operating performance and demand trends during the quarter ended March 31, 2025. This is based on internal unaudited management reports. This will be followed by a detailed performance update, post the approval of the Q4 FY25 financial results by the Board of Directors.
Shares of Godrej Consumer Products Limited was last trading in BSE at Rs. 1157.15 as compared to the previous close of Rs. 1161.90. The total number of shares traded during the day was 6361 in over 1340 trades.
The stock hit an intraday high of Rs. 1170.85 and intraday low of 1142.45. The net turnover during the day was Rs. 7354908.00.